The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

Description

The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children aged 4-11 years in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?

Conditions

Asthma in Children, Depression

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children aged 4-11 years in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?

Testing the Effectiveness and Implementation of an Evidence-Based Maternal Depression Treatment in an Urban Pediatric Asthma Clinic

The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

Condition
Asthma in Children
Intervention / Treatment

-

Contacts and Locations

Washington

Children's National Hospital, Washington, District of Columbia, United States, 20010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary caregiver of the child with asthma seen at the community-based asthma clinic
  • * Female (self-identified)
  • * Black (self-identified)
  • * ≥ 18 years of age
  • * English-speaking
  • * PHQ-9 ≥ 10 during standardized screening at the child with asthma's clinic visit
  • * Ages 4-11 years
  • * Publicly insured
  • * Physician-diagnosed persistent asthma
  • * Acutely suicidal (high risk on the C-SSRS at child's asthma clinic visit)
  • * Bipolar disorder or mania
  • * Schizophrenia
  • * Current substance abuse/dependence
  • * Current serious physical intimate partner violence (IPV)
  • * Significant medical co-morbidity (e.g., disorders of the cardiorespiratory system, significant developmental delay, diabetes, seizure disorder, and sickle cell disease)
  • * Enrolled in another intervention with a behavioral component and/or novel asthma therapeutics

Ages Eligible for Study

4 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Children's National Research Institute,

Rachel Margolis, PhD, MSW, PRINCIPAL_INVESTIGATOR, Children's National Research Institute

Study Record Dates

2027-04-30